Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx

Background<p>Lymphedema, a chronic condition involving lymphatic fluid accumulation, affects over 250 million people worldwide. Liposuction (LS), introduced in 1989, offers a minimally invasive option for non-pitting lymphedema by reducing fibrotic and hypertrophic tissues. However, LS require...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Junzhe Chen (5729912) (author)
Autres auteurs: Xiyao Feng (8949869) (author), Yan Zhou (6523) (author), Yun Wang (32846) (author), Shune Xiao (4109980) (author), Chengliang Deng (10529766) (author)
Publié: 2025
Sujets:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1849927624223096832
author Junzhe Chen (5729912)
author2 Xiyao Feng (8949869)
Yan Zhou (6523)
Yun Wang (32846)
Shune Xiao (4109980)
Chengliang Deng (10529766)
author2_role author
author
author
author
author
author_facet Junzhe Chen (5729912)
Xiyao Feng (8949869)
Yan Zhou (6523)
Yun Wang (32846)
Shune Xiao (4109980)
Chengliang Deng (10529766)
author_role author
dc.creator.none.fl_str_mv Junzhe Chen (5729912)
Xiyao Feng (8949869)
Yan Zhou (6523)
Yun Wang (32846)
Shune Xiao (4109980)
Chengliang Deng (10529766)
dc.date.none.fl_str_mv 2025-11-26T05:15:27Z
dc.identifier.none.fl_str_mv 10.3389/fonc.2025.1651472.s002
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Table_3_Outcomes_after_liposuction-based_treatment_of_lymphedema_a_systematic_review_and_meta-analysis_docx/30717836
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Oncology and Carcinogenesis not elsewhere classified
lymphedema
surgery
integrated surgery
liposuction
meta-analysis
dc.title.none.fl_str_mv Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description Background<p>Lymphedema, a chronic condition involving lymphatic fluid accumulation, affects over 250 million people worldwide. Liposuction (LS), introduced in 1989, offers a minimally invasive option for non-pitting lymphedema by reducing fibrotic and hypertrophic tissues. However, LS requires ongoing compression therapy as it does not address the underlying lymphatic dysfunction. Although integrated approaches combining LS with lymphovenous anastomosis (LVA) or vascularized lymph node transfer (VLNT) aim to address both fluid removal and lymphatic repair, there remains a lack of consensus regarding the efficacy of these integrated liposuction-based treatments.</p>Methods<p>A systematic review and meta-analysis conducted by the PRISMA and AMSTAR guidelines included studies from 1996 to 2024. Fifty-two studies (n=2,334) were reviewed and 23 (n=1,028) were analyzed quantitatively. Outcomes mainly included limb volume reduction, reliance on conservative treatment, improvement in infection rates, and improvement in the quality of life (QOL).</p>Results<p>LS-based treatments significantly reduce volume in both upper and lower limbs (91.08% and 92.03%). Standalone LS reduced limb volume by 99.74% but relied on continuous compression therapy. Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. Furthermore, LS-based interventions were associated with a potential reduction in infection episodes, thereby providing long-term benefits.</p>Conclusion<p>Liposuction-based therapies effectively manage lymphedema by reducing limb volume and may reduce infections, while improving QOL. In addition, integrated approaches offer additional benefits by directly addressing lymphatic dysfunction and reducing reliance on compression therapy. Standardized methodologies and long-term studies are needed to refine the clinical guidelines and optimize outcomes. </p>Systematic review registration<p>https://www.crd.york.ac.uk/PROSPERO, identifier CRD42024616130.</p>
eu_rights_str_mv openAccess
id Manara_41a663c000603a03bba001a432a338ae
identifier_str_mv 10.3389/fonc.2025.1651472.s002
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30717836
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docxJunzhe Chen (5729912)Xiyao Feng (8949869)Yan Zhou (6523)Yun Wang (32846)Shune Xiao (4109980)Chengliang Deng (10529766)Oncology and Carcinogenesis not elsewhere classifiedlymphedemasurgeryintegrated surgeryliposuctionmeta-analysisBackground<p>Lymphedema, a chronic condition involving lymphatic fluid accumulation, affects over 250 million people worldwide. Liposuction (LS), introduced in 1989, offers a minimally invasive option for non-pitting lymphedema by reducing fibrotic and hypertrophic tissues. However, LS requires ongoing compression therapy as it does not address the underlying lymphatic dysfunction. Although integrated approaches combining LS with lymphovenous anastomosis (LVA) or vascularized lymph node transfer (VLNT) aim to address both fluid removal and lymphatic repair, there remains a lack of consensus regarding the efficacy of these integrated liposuction-based treatments.</p>Methods<p>A systematic review and meta-analysis conducted by the PRISMA and AMSTAR guidelines included studies from 1996 to 2024. Fifty-two studies (n=2,334) were reviewed and 23 (n=1,028) were analyzed quantitatively. Outcomes mainly included limb volume reduction, reliance on conservative treatment, improvement in infection rates, and improvement in the quality of life (QOL).</p>Results<p>LS-based treatments significantly reduce volume in both upper and lower limbs (91.08% and 92.03%). Standalone LS reduced limb volume by 99.74% but relied on continuous compression therapy. Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. Furthermore, LS-based interventions were associated with a potential reduction in infection episodes, thereby providing long-term benefits.</p>Conclusion<p>Liposuction-based therapies effectively manage lymphedema by reducing limb volume and may reduce infections, while improving QOL. In addition, integrated approaches offer additional benefits by directly addressing lymphatic dysfunction and reducing reliance on compression therapy. Standardized methodologies and long-term studies are needed to refine the clinical guidelines and optimize outcomes. </p>Systematic review registration<p>https://www.crd.york.ac.uk/PROSPERO, identifier CRD42024616130.</p>2025-11-26T05:15:27ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.3389/fonc.2025.1651472.s002https://figshare.com/articles/dataset/Table_3_Outcomes_after_liposuction-based_treatment_of_lymphedema_a_systematic_review_and_meta-analysis_docx/30717836CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307178362025-11-26T05:15:27Z
spellingShingle Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
Junzhe Chen (5729912)
Oncology and Carcinogenesis not elsewhere classified
lymphedema
surgery
integrated surgery
liposuction
meta-analysis
status_str publishedVersion
title Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
title_full Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
title_fullStr Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
title_full_unstemmed Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
title_short Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
title_sort Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx
topic Oncology and Carcinogenesis not elsewhere classified
lymphedema
surgery
integrated surgery
liposuction
meta-analysis